Hakverdi, Ali UlviGüngören, ArifDolapçio?lu, Kenan2024-09-192024-09-1920071016-5126https://hdl.handle.net/20.500.12483/15252Stres urinary incontinence (SUI) is a major clinical problem in adult women and the incidence of the condition increases with age. More than 200 million people worldwide live with SUI. Conservative treatment such as pelvic floor muscle exercises and pharmacotherapy are considered the first-line option for cases that are not severe. More than 150 operative procedures for SUI have been described during the past hundred years. Long term success rate of these procedures are 80 %-90 % using slings, although slings are associated with a high incidence of voiding difficulties and detrusor over activity, erode into the vagina or urinary tract. In the last two decades, injections of bulking agents have been widely used to treat genuine stres urinary incontinence. A large amount of literature has recently appeared on the subject, with success rates varying from 50 % to 95 %. Periurethral injections are less invasive and easily performed with local anesthesia on an outpatients basis. The "implacer" also has been designed for "non- endoscopic" treatment of female SUI. Various bulking agents have been used, such as autologous fat tissue, GAX-collagen, silicone microimplants, NASHA/Dex gel. . . The ideal bulking agent has not been find for periurethral injection at this time in the world. The aim of this article is to use evidence-based criteria to review publications about the periurethral injections on the evaluation and management of stress urinary incontinence in women.trinfo:eu-repo/semantics/closedAccessPeriurethral injectionStress incontinenceReview Article2142052092-s2.0-47049083476N/A